Approval · Notice of Compliance 8532 · 2007
MABCAMPATH: Notice of Compliance 8532
Issued January 19, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8532
- Date
- January 19, 2007
- Company
- Genzyme CorporationCambridge, Massachusetts, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength and presentation
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MABCAMPATH | 02290960 | Marketed |
Medicinal ingredients
- ALEMTUZUMAB 30 MG per ML